EUVIMEDEUVIMED entdecken
Crossref

Pharmacokinetics of Enrofloxacin and Its Metabolite Ciprofloxacin in Nanyang Cattle

Fang Yang, Long-Ji Sun, Fan Yang, Shi-Hao Li, Yu-Xin Chen, Wen-Rui Wang

Journal of Veterinary Pharmacology and Therapeutics · 2025

DOI: 10.1111/jvp.13478 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Veterinary Pharmacology and Therapeutics, 2025. Verfasst von Fang Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Animal Science and Technology, Henan University of Science and Technology, Luoyang, China. Hauptthemen laut MEDLINE: Enrofloxacin, Ciprofloxacin, Anti-Bacterial Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: The Natural Science Foundation of Henan Province, Natural Science Foundation of Henan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The objective of this study was to determine the pharmacokinetics of enrofloxacin and its metabolite, ciprofloxacin, in Nanyang cattle after a single intravenous (IV), and intramuscular (IM) administration of enrofloxacin at 2.5 mg/kg body weight (BW). Blood samples were collected at predetermined time points. Enrofloxacin and ciprofloxacin concentrations in plasma were simultaneously determined using a high‐performance liquid chromatography (HPLC) assay method and subjected to a non‐compartmental analysis. After IV administration, enrofloxacin had a mean (±SD) volume of distribution at steady state ( V SS ) of 1.394 ± 0.349 L/kg, a terminal half‐life ( t 1/2 λz ) of 3.592 ± 1.205 h, and a total body clearance (Cl) of 0.675 ± 0.16 L/h/kg. After IM administration, enrofloxacin was absorbed relatively slowly but completely, with a mean absorption time (MAT) of 6.051 ± 1.107 h and a bioavailability of 99.225 ± 7.389%. Both compounds were detected simultaneously in most plasma samples following both routes of administration, indicating efficient biotransformation of enrofloxacin to ciprofloxacin. After IV injection, the peak concentration ( C max ) of ciprofloxacin was 0.315 ± 0.017 μg/mL, observed at 0.958 ± 0.102 h. Following IM injection, the corresponding values were 0.071 ± 0.006 μg/mL and 3 ± 1.095 h, respectively. Following IV and IM administration, the conversion ratio of enrofloxacin to ciprofloxacin was calculated as 59.2 ± 9.6% and 31.2 ± 7.7%, respectively. The present results demonstrated favorable pharmacokinetic profiles for enrofloxacin, characterized by complete absorption with relatively slow kinetics, extensive distribution, efficient biotransformation to ciprofloxacin, and prolonged elimination in Nanyang cattle.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EnrofloxacinCiprofloxacinAnti-Bacterial AgentsAnimalsCattleInjections, IntramuscularHalf-LifeInjections, IntravenousArea Under CurveMaleFemaleFluoroquinolones

Stichwörter der Autor:innen

HPLCNanyang cattleciprofloxacinenrofloxacinpharmacokinetics

Substanzen

EnrofloxacinCiprofloxacinAnti-Bacterial AgentsFluoroquinolones

Autor:innen und Institutionen

  • College of Animal Science and Technology, Henan University of Science and Technology, Luoyang, China.

Förderung

  • The Natural Science Foundation of Henan Province
  • Natural Science Foundation of Henan Province

Zitieren

APA

Yang, F., Sun, L. J., Yang, F., Li, S. H., Chen, Y. X., & Wang, W. R. (2025). Pharmacokinetics of Enrofloxacin and Its Metabolite Ciprofloxacin in Nanyang Cattle. Journal of Veterinary Pharmacology and Therapeutics. https://doi.org/10.1111/jvp.13478

Vancouver

Yang F, Sun LJ, Yang F, Li SH, Chen YX, Wang WR. Pharmacokinetics of Enrofloxacin and Its Metabolite Ciprofloxacin in Nanyang Cattle. Journal of Veterinary Pharmacology and Therapeutics. 2025. doi:10.1111/jvp.13478

BibTeX
@article{Yang2025,
  author = {Yang, Fang and Sun, Long-Ji and Yang, Fan and Li, Shi-Hao and Chen, Yu-Xin and Wang, Wen-Rui},
  title = {Pharmacokinetics of Enrofloxacin and Its Metabolite Ciprofloxacin in Nanyang Cattle},
  journal = {Journal of Veterinary Pharmacology and Therapeutics},
  year = {2025},
  doi = {10.1111/jvp.13478}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche